@article{fdae594fa70b4301b26162775d18a3d4,
title = "Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5 T MR-linear accelerator hybrid system: A prospective R-IDEAL stage 2a imaging biomarker characterization/pre-qualification study",
abstract = "Objectives: We aim to characterize the serial quantitative apparent diffusion coefficient (ADC) changes of the target disease volume using diffusion-weighted imaging (DWI) acquired weekly during radiation therapy (RT) on a 1.5 T MR-Linac and correlate these changes with tumor response and oncologic outcomes for head and neck squamous cell carcinoma (HNSCC) patients as part of a programmatic R-IDEAL biomarker characterization effort. Methods: Thirty patients with HNSCC who received curative-intent RT at MD Anderson Cancer Center, were included. Baseline and weekly MRI were obtained, and various ADC parameters were extracted from the regions of interest (ROIs). Baseline and weekly ADC parameters were correlated with response during and after RT, and the recurrence using the Mann-Whitney U test. The Wilcoxon signed-rank test was used to compare the weekly ADC versus baseline values. Weekly volumetric changes (Δvolume) for each ROI were correlated with ΔADC using Spearman's Rho test. Recursive partitioning analysis (RPA) identified the optimal ΔADC threshold associated with different oncologic outcomes. Results: There was a significant rise in all ADC parameters at different time points of RT compared to baseline for both gross primary disease (GTV-P) and gross nodal disease volumes (GTV-N). The increased ADC values for GTV-P were statistically significant only for primary tumors achieving complete remission (CR) during RT. RPA identified GTV-P ΔADC 5th percentile > 13% at the mid-RT as the most significant parameter associated with primary tumors{\textquoteright} CR during RT (p < 0.001). There was a significant decrease in residual volume of both GTV-P & GTV-N throughout the course of RT. A significant negative correlation between mean ΔADC and Δvolume for GTV-P at the 3rd and 4th week of RT was detected (r = −0.39, p = 0.044 & r = −0.45, p = 0.019, respectively). Conclusion: Assessment of ADC kinetics at regular intervals throughout RT seems to be correlated with RT response. Further studies with larger cohorts and multi-institutional data are needed for validation of ΔADC as a model for prediction of response to RT.",
keywords = "ADC, Diffusion, DWI, Head and neck cancer, MR-Linac, Oncologic outcomes",
author = "El-Habashy, {Dina M.} and Wahid, {Kareem A.} and Renjie He and Brigid McDonald and Jillian Rigert and Mulder, {Samuel J.} and Lim, {Tze Yee} and Xin Wang and Jinzhong Yang and Yao Ding and Naser, {Mohamed A.} and Ng, {Sweet Ping} and Houda Bahig and Salzillo, {Travis C.} and Preston, {Kathryn E.} and Moamen Abobakr and Shehata, {Mohamed A.} and Elkhouly, {Enas A.} and Alagizy, {Hagar A.} and Hegazy, {Amira H.} and Mustefa Mohammadseid and Chris Terhaard and Marielle Philippens and Rosenthal, {David I.} and Jihong Wang and Lai, {Stephen Y.} and Alex Dresner and Christodouleas, {John C.} and Mohamed, {Abdallah Sherif Radwan} and Fuller, {Clifton D.}",
note = "Funding Information: Efforts by Drs. Fuller, Christodouleas, Dresner, Mohamed, Naser, He, Mulder, and Preston are supported by NIH National Institute of Dental and Craniofacial Research (NIDCR) Academic Industrial Partnership Grant (R01DE028290) and the Administrative Supplement to Support Collaborations to Improve AIML-Readiness of NIH-Supported Data (R01DE028290-04S2). Dr. El-Habashy received prior salary support from the Egyptian Ministry of Higher Education. Drs. McDonald and Wahid received prior salary support during study execution from the NIDCR Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship Program (F31DE029093, F31DE031502). Drs. McDonald, Wahid, and Fuller receive related salary support from the NCI Ruth L. Kirschstein National NRSA Institutional Research Training Grant Award via the MD Anderson Image Guided Cancer Therapy Training Program (T32CA261856). Dr. Jillian Rigert Receives salary support from the NIDCR Diversity Supplement (3R01DE028290-02S1). Dr. Yang receive unrelated funding from Radiation Oncology Institute. Drs. Fuller, Mohamed, and Lai receive unrelated funding from the NIDCR Establishing Outcome Measures for Clinical Studies of Oral and Craniofacial Diseases and Conditions award (R01DE025248). Dr. Fuller received/receives unrelated funding and salary support from: NSF/NIH Interagency Smart and Connected Health (SCH) Program (R01CA257814); NIH National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Programs for Residents and Clinical Fellows Grant (R25EB025787); NIH NIDCR Exploratory/Developmental Research Grant Program (R21DE031082); NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672); Patient-Centered Outcomes Research Institute (PCS-1609-36195) sub-award from Princess Margaret Hospital; National Science Foundation (NSF) Division of Civil, Mechanical, and Manufacturing Innovation (CMMI) grant (NSF 1933369). Dr. Fuller receives grant and infrastructure support from MD Anderson Cancer Center via: the Charles and Daneen Stiefel Center for Head and Neck Cancer Oropharyngeal Cancer Research Program; the Program in Image-guided Cancer Therapy; and the NIH/NCI Cancer Center Support Grant (CCSG) Radiation Oncology and Cancer Imaging Program (P30CA016672). Dr. Fuller has received direct industry grant/in-kind support, honoraria, and travel funding from Elekta AB. Dr. Fuller has received travel, speaker honoraria and/or registration fee waiver unrelated to this project from: The American Association for Physicists in Medicine; the University of Alabama-Birmingham; The American Society for Clinical Oncology; The Royal Australian and New Zealand College of Radiologists; The American Society for Radiation Oncology; The Radiological Society of North America; and The European Society for Radiation Oncology. Publisher Copyright: {\textcopyright} 2023 The Author(s)",
year = "2023",
month = sep,
doi = "10.1016/j.ctro.2023.100666",
language = "English",
volume = "42",
}